Mahaflox-D Eye Drop is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone 0.1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammatory conditions. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively targeting a wide range of Gram-positive and Gram-negative pathogens. Dexamethasone provides anti-inflammatory action by suppressing the release of inflammatory mediators, reducing ocular swelling, redness, and discomfort. Mahaflox-D Eye Drop is commonly prescribed for bacterial conjunctivitis, keratitis, and other ocular infections where inflammation is significant. It is essential to use this medication under strict medical supervision due to the potential side effects associated with corticosteroid use, such as increased intraocular pressure and delayed wound healing. Patients should adhere to the prescribed dosage and duration to prevent resistance development and ensure optimal therapeutic outcomes. Contraindications include viral, fungal, or mycobacterial eye infections. Caution is advised in patients with glaucoma or a history of corticosteroid sensitivity. Regular ophthalmic evaluations are recommended during prolonged therapy.